A phase I pharmacokinetic study of bexarotene with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Jordi Rodon
Charlotte D. Jacobs
Quincy Chu
Eric K. Rowinsky
Arturo Lopez-Anaya
Chris H. Takimoto
Heather A. Wakelee
机构：
[1] Cancer Therapy and Research Center at The University of Texas Health Science Center,Institute for Drug Development
[2] Stanford University and Stanford Cancer Institute,Division of Oncology, Department of Medicine
[3] Eisai,undefined
[4] Inc.,undefined
[5] Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology,undefined
[6] Cross Cancer Institute,undefined
[7] University of Alberta,undefined
[8] Oncodrugs Consulting,undefined
[9] Forest Laboratories,undefined
[10] Inc.,undefined
[11] Ortho Biotech Oncology R&D/Johnson & Johnson,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词：
Bexarotene; Carboplatin; Paclitaxel; Pharmacokinetics; Phase I;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：825 / 834
页数：9
相关论文
共 50 条
  • [31] Phase I and Pharmacokinetic Study of IV Vinflunine in Combination With Carboplatin in Chemonaive Patients With Advanced Non-small Cell Lung Cancer
    Tournoux-Facon, Caroline
    Robinet, Gilles
    Pinel, Marie-Claire
    Ferre, Pierre
    Tourani, Jean-Marc
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (04): : 378 - 385
  • [32] Paclitaxel and Carboplatin in Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Sadic, Murat
    Alavi, Abass
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2016, 7
  • [33] Tolerability and activity of weekly paclitaxel and carboplatin in advanced non-small cell lung cancer (NSCLC)
    Fabi, A
    De Marco, S
    Barduagni, M
    Gamucci, T
    Cortesi, E
    De Marinis, F
    Ferraresi, V
    Saltarelli, R
    Gabriele, A
    Accettura, C
    Cognetti, F
    ANNALS OF ONCOLOGY, 2000, 11 : 4 - 4
  • [34] Carboplatin/nab-Paclitaxel and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): Phase 1 Results
    Gentzler, R. D.
    Mohindra, N. A.
    Hanna, N.
    Chae, Y. K.
    Jalal, S. I.
    Hall, R.
    Villaflor, V. M.
    Reckamp, K. L.
    Koczywas, M.
    Sullivan, D.
    Wood, L.
    Patel, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (01): : 236 - 236
  • [35] Phase I/II study of atrasentan (A) in combination with carboplatin (C) and paclitaxel (P) in chemonaive patients (pts) with advanced non-small cell lung cancer (NSCLC).
    Chiappori, A
    Haura, E
    Williams, C
    Simon, G
    Antonia, S
    Cantor, A
    Burton, MK
    Lush, R
    Sullivan, DM
    Bepler, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 646S - 646S
  • [36] Concurrent chemoradiotherapy with paclitaxel and carboplatin for locoregionally advanced non-small cell lung cancer (NSCLC)
    Kaplanova, J.
    Tomiskova, M.
    Babickova, L.
    Kadlec, B.
    Slampa, P.
    Skrickova, J.
    LUNG CANCER, 2006, 52 : S34 - S34
  • [37] A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer
    Soejima, Kenzo
    Naoki, Katsuhiko
    Ishioka, Kota
    Nakamura, Morio
    Nakatani, Michie
    Kawada, Ichiro
    Watanabe, Hideo
    Nakachi, Ichiro
    Yasuda, Hiroyuki
    Satomi, Ryosuke
    Nakayama, Sohei
    Yoda, Satoshi
    Ikemura, Sinnosuke
    Terai, Hideki
    Sato, Takashi
    Ohgino, Keiko
    Arai, Daisuke
    Tani, Tetsuo
    Kuroda, Aoi
    Nishino, Makoto
    Betsuyaku, Tomoko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (03) : 513 - 519
  • [38] A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer
    Kenzo Soejima
    Katsuhiko Naoki
    Kota Ishioka
    Morio Nakamura
    Michie Nakatani
    Ichiro Kawada
    Hideo Watanabe
    Ichiro Nakachi
    Hiroyuki Yasuda
    Ryosuke Satomi
    Sohei Nakayama
    Satoshi Yoda
    Sinnosuke Ikemura
    Hideki Terai
    Takashi Sato
    Keiko Ohgino
    Daisuke Arai
    Tetsuo Tani
    Aoi Kuroda
    Makoto Nishino
    Tomoko Betsuyaku
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 513 - 519
  • [39] Phase II study of carboplatin, irinotecan, and thalidomide in patients with advanced non-small cell lung cancer (NSCLC).
    Miller, AA
    Case, D
    Atkins, J
    Giguere, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 649S - 649S
  • [40] Vinflunine (VFL) in combination with carboplatin (CBDCA) for treatment of advanced non-small cell lung cancer (NSCLC) in chemonaive patients (pts): Phase I and pharmacokinetic study
    Robinet, G
    Afenjar, K
    Gouva, S
    Planchard, D
    Zorza, G
    Tourani, J
    LUNG CANCER, 2005, 49 : S267 - S267
12345